Skip to main content

Advertisement

SpringerLink
Log in

QCT bone mineral density responses to 1 year of oral bisphosphonate after total knee replacement for knee osteoarthritis

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Bone mineral density (BMD) declined in more than half (53.7%) of post-total knee arthroplasty (TKA) patients (44 of the 82) after 1 year of oral bisphosphonate treatment, and that this decline was significant in bilateral TKA patients.

Introduction

TKA has proven to be an extremely successful procedure in terms of improving ambulatory function. However, the effects of such improvements in ambulatory function and of bisphosphonate on axial BMD have not been established. The purpose of this study was to determine the effect of 1 year of oral bisphosphonate in postmenopausal patients that have undergone TKA and to identify factors related to BMD changes using lumbar spine quantitative computed tomography (QCT).

Methods

Eighty-two postmenopausal women that underwent primary TKA for knee osteoarthritis and who received once-weekly oral alendronate 70 mg for 12 months after TKA were enrolled. The effect of 1 year of oral bisphosphonate treatment post-TKA and the factors related to general lumbar spine BMD changes by using QCT were determined.

Results

Some 53.7% of patients (44 of the 82) experienced an average lumbar spine QCT BMD decline of −6 mg/ml (range −15 to −0.5 mg/ml) after 1 year of oral bisphosphonate treatment, whereas the remaining 38 patients (46.3%) experienced an average increase of 6.8 mg/ml (range 0.6 to 15.7 mg/ml). Logistic and linear regression analysis showed that bilateral TKA was significantly related to a BMD decline (p < 0.05). Other factors, such as, age, body mass index, number of comorbidities, and Knee Society scores were not found to be significantly related to BMD response.

Conclusions

BMD declined in more than half (53.7%) of the patients after bisphosphonate treatment, and that this decline was significant in bilateral TKA patients. We believe that reduced mobility during rehabilitation was probably responsible for these BMD reductions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nevitt MC, Lane NE, Scott JC, Hochberg MC, Pressman AR, Genant HK, Cummings SR (1995) Radiographic osteoarthritis of the hip and bone mineral density. Arthritis Rheum 38:907–916

    Article  PubMed  CAS  Google Scholar 

  2. Hannan MT, Anderson JJ, Zhang Y, Levy D, Felson DT (1993) Bone mineral density and knee osteoarthritis in elderly men and women. Arthritis Rheum 36:1671–1680

    Article  PubMed  CAS  Google Scholar 

  3. Arden NK, Crozier S, Smith H, Anderson F, Edwards C, Raphael H, Cooper C (2006) Knee pain, knee osteoarthritis, and the risk of fracture. Arthritis Rheum 55:610–615

    Article  PubMed  Google Scholar 

  4. Prieto-Alhambra D, Javaid MK, Judge A, Maskell J, Kiran A, Cooper C, Arden NK (2011) Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis. Osteoporos Int 22:1555–1571

    Article  PubMed  CAS  Google Scholar 

  5. Minoda Y, Ikebuchi M, Kobayashi H, Iwaki H, Inori F, Nakamura H (2010) A cemented mobile-bearing total knee replacement prevents periprosthetic loss of bone mineral density around the femoral component: a matched cohort study. J Bone Joint Surg Br 92-B(6):794–798

    Article  Google Scholar 

  6. van Loon CJ, Oyen WJ, de Waal Malefijt MC, Verdonschot N (2001) Distal femoral bone mineral density after total knee arthroplasty: a comparison with general bone mineral density. Arch Orthop Trauma Surg 121:282–285

    Article  PubMed  Google Scholar 

  7. Abu-Rajab RB, Watson WS, Walker B, Roberts J, Gallacher SJ, Meek RM (2006) Peri-prosthetic bone mineral density after total knee arthroplasty: cemented versus cementless fixation. J Bone Joint Surg Br 88-B:606–613

    Article  Google Scholar 

  8. Soininvaara TA, Jurvelin JS, Miettinen HJA, Suomalainen OT, Alhava EM, Kroger PJ (2002) Effect of alendronate on periprosthetic bone loss after total knee Arthroplasty: a one-year, randomized, controlled trial of 19 patient. Calcif Tissue Int 71:472–477

    Article  PubMed  CAS  Google Scholar 

  9. Lewiecki EM, Keaveny TM, Kopperdahl DL, Genant HK, Engelke K, Fuerst T, Kivitz A, Davies RY, Fitzpatrick LA (2009) Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 94:171–180

    Article  PubMed  CAS  Google Scholar 

  10. Hochberg MC, Ross PD, Black D, Cummings SR, Genant HK, Nevitt MC, Barrett-Connor E, Musliner T, Thompson D (1999) Large increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Arthritis Rheum 42:1246–1254

    Article  PubMed  CAS  Google Scholar 

  11. Powell RS, Pulido P, Tuason MS, Colwell CW Jr, Ezzet KA (2006) Bilateral vs unilateral total knee arthroplasty: a patient-based comparison of pain levels and recovery of ambulatory skills. J Arthroplasty 21:642–649

    Article  PubMed  Google Scholar 

  12. Sebba AI (2008) Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment. Clin Ther 30:443–452

    Article  PubMed  CAS  Google Scholar 

  13. Recker RR, Gallagher R, Maccosbe PE (2005) Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 80:856–861

    Article  PubMed  Google Scholar 

  14. Francis RM (2004) Non-response to osteoporosis treatment. J Br Menopause Soc 10:76–80

    PubMed  Google Scholar 

  15. Bonnick SL, Johnston CC Jr, Kleerekoper M, Lindsay R, Miller P, Sherwood L, Siris E (2001) Importance of precision in bone density measurements. J Clin Densitom 4:105–111

    Article  PubMed  CAS  Google Scholar 

  16. Oppenheimer L, Kher U (1999) The impact of measurement error on the comparison of two treatments using a responder analysis. Stat Med 18:2177–2188

    Article  PubMed  CAS  Google Scholar 

  17. Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Lewiecki EM, Silverman S (2008) Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom 11:75–91

    Article  PubMed  Google Scholar 

  18. Carey JJ (2005) What is a ‘failure’ of bisphosphonate therapy for osteoporosis? Cleve Clin J Med 72:1033–1039

    Article  PubMed  Google Scholar 

  19. Kilgus DJ, Shimaoka EE, Tipton JS, Eberle RW (1993) Dual-energy X-ray absorptiometry measurement of bone mineral density around porous-coated cementless femoral implants. Methods and preliminary results. J Bone Joint Surg Br 75-B:279–287

    Google Scholar 

  20. Delmas PD, Seeman E (2004) Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone 34:599–604

    Article  PubMed  CAS  Google Scholar 

  21. Engelke K, Adams JE, Armbrecht G, Augat P, Bogado CE, Bouxsein ML, Felsenberg D, Ito M, Prevrhal S, Hans DB, Lewiecki EM (2008) Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults. J Clin Densitom 11:123–162

    Article  PubMed  Google Scholar 

  22. Prieto-Alhambra D, Javaid MK, Judge A, Maskell J, Judge A, Nevitt M, Cooper C, Arden NK (2010) Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study. Ann Rheum Dis 70:134–138

    Article  PubMed  Google Scholar 

  23. Birdsall PD, Hayes JH, Cleary R, Pinder IM, Moran CG, Sher JL (1999) Health outcome after total knee replacement in the very elderly. J Bone Joint Surg Br 81-B:660–662

    Article  Google Scholar 

  24. Lalmohamed A, Opdam F, Arden NK, Prieto-Alhambra D, van Staa T, Leufkens HG, de Vries F (2012) Knee arthroplasty and risk of hip fracture: a population-based, case–control study. Calcif Tissue Int 90(2):144–150

    Article  PubMed  CAS  Google Scholar 

  25. Prieto-Alhambra D, Javaid MK, Judge A, Maskell J, Kiran A, de Vries F, Cooper C, Arden NK (2011) Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use. Arthritis Rheum 63:992–1001

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Hanyang University College of Medicine, Seoul, Republic of Korea

    J. K. Lee, C. H. Lee & C. H. Choi

Authors
  1. J. K. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. H. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. H. Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. H. Choi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, J.K., Lee, C.H. & Choi, C.H. QCT bone mineral density responses to 1 year of oral bisphosphonate after total knee replacement for knee osteoarthritis. Osteoporos Int 24, 287–292 (2013). https://doi.org/10.1007/s00198-012-1925-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-012-1925-x

Keywords

Search

Navigation